Shares of Invitae NVTA decreased in after-market trading after the company reported Q1 results.
Quarterly Results
Earnings per share rose 21.25% over the past year to ($0.63), which missed the estimate of ($0.59).
Revenue of $103,621,000 higher by 61.28% year over year, which beat the estimate of $101,460,000.
Guidance
Earnings guidance hasn't been issued by the company for now.
Revenue guidance hasn't been issued by the company for now.
Conference Call Details
Date: May 04, 2021
Time: 04:30 PM
ET Webcast URL: https://www.directeventreg.com/der/validateConferenceId.action
Recent Stock Performance
Company's 52-week high was at $61.59
52-week low: $14.84
Price action over last quarter: down 34.68%
Company Overview
Invitae Corp operates as a genetic information company in diagnostic and research industry. The company's tests include multiple genes associated with hereditary cancer, neurological disorders, cardiovascular disorders, pediatric disorders, metabolic disorders and other hereditary conditions.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.